Loading clinical trials...
Loading clinical trials...
A Randomized Clinical Trial of ab Interno Canaloplasty and Trabeculotomy With the OMNI Surgical System Compared to Standard Medical Treatment as a Standalone Procedure in Patients With Primary Open Angle Glaucoma
Conditions
Interventions
OMNI Surgical System
Latanoprost plus adjunctive glaucoma medication
Locations
2
United States
North Bay Eye Associates
Petaluma, California, United States
University Eye Specialists
Maryville, Tennessee, United States
Start Date
August 21, 2024
Primary Completion Date
January 20, 2025
Completion Date
January 20, 2025
Last Updated
January 29, 2025
NCT07390890
NCT05902871
NCT07076303
NCT06865144
NCT05564091
NCT05557721
Lead Sponsor
Sight Sciences, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions